Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 1,098 -0.83%
30 Apr - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership
The company is India’s 2nd largest hospital chain in terms of hospital revenue, EBITDA, and market capitalization. [1]

Website BSE NSE
  • Market Cap ₹ 1,06,770 Cr.
  • Current Price ₹ 1,098
  • High / Low ₹ 1,228 / 743
  • Stock P/E 101
  • Book Value ₹ 90.5
  • Dividend Yield 0.14 %
  • ROCE 16.0 %
  • ROE 13.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 780% CAGR over last 5 years

Cons

  • Stock is trading at 12.1 times its book value
  • Company has a low return on equity of 13.4% over last 3 years.
  • Promoter holding has decreased over last 3 years: -26.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Allcap Nifty 500 BSE Healthcare Nifty Midcap 100 Nifty Infrastructure

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
976 937 1,067 1,137 1,142 1,215 1,285 1,363 1,335 1,423 1,543 1,707 1,868
728 729 802 818 828 874 948 976 949 1,041 1,156 1,257 1,369
Operating Profit 247 209 265 319 314 340 337 387 386 382 387 451 499
OPM % 25% 22% 25% 28% 28% 28% 26% 28% 29% 27% 25% 26% 27%
46 26 31 26 45 40 41 45 46 45 35 41 -40
Interest 25 22 22 22 20 20 19 9 11 21 24 34 52
Depreciation 55 58 57 58 57 60 56 58 61 70 77 84 98
Profit before tax 213 154 216 265 281 301 303 366 360 336 321 374 309
Tax % 11% 20% 20% -72% 21% 17% 21% 24% 20% 25% 26% 25% 23%
190 124 173 457 222 251 240 277 289 252 236 282 239
EPS in Rs 1.96 1.28 1.78 4.72 2.29 2.58 2.47 2.85 2.98 2.59 2.43 2.90 2.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,608 1,729 1,691 1,884 2,508 3,937 4,563 5,406 6,542
1,467 1,616 1,535 1,595 2,101 2,986 3,322 3,914 4,823
Operating Profit 141 113 156 289 407 951 1,241 1,492 1,719
OPM % 9% 7% 9% 15% 16% 24% 27% 28% 26%
59 65 56 72 -122 110 139 178 80
Interest 100 99 101 153 179 101 84 60 131
Depreciation 96 94 103 120 174 221 232 245 329
Profit before tax 5 -15 8 89 -69 739 1,064 1,365 1,340
Tax % -236% 65% 102% -7% 67% 18% -4% 23%
16 -25 -0 95 -138 605 1,104 1,058 1,008
EPS in Rs 0.29 -0.47 -0.06 1.77 -1.42 6.24 11.37 10.88 10.38
Dividend Payout % 0% 0% 0% 0% 0% 0% 9% 14%
Compounded Sales Growth
10 Years: %
5 Years: 26%
3 Years: 29%
TTM: 26%
Compounded Profit Growth
10 Years: %
5 Years: 780%
3 Years: 96%
TTM: 0%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 38%
1 Year: 31%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 13%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 537 537 537 537 966 970 971 972 972
Reserves 655 627 426 450 4,673 5,313 6,439 7,436 7,827
874 981 1,003 1,516 1,101 913 689 1,299 1,768
1,080 1,157 1,389 1,300 1,803 1,993 2,003 2,293 2,560
Total Liabilities 3,146 3,302 3,355 3,804 8,543 9,189 10,102 12,000 13,127
2,244 2,227 2,192 2,380 6,536 7,018 7,039 8,784 9,506
CWIP 46 38 87 6 27 151 252 553 588
Investments 0 0 1 1 1 1 1 2 3
856 1,036 1,075 1,418 1,980 2,020 2,810 2,661 3,030
Total Assets 3,146 3,302 3,355 3,804 8,543 9,189 10,102 12,000 13,127

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
156 166 89 250 118 741 1,284 1,122
-104 -124 -17 -127 206 -764 -102 -1,253
-48 -48 -74 144 191 -294 -289 -264
Net Cash Flow 4 -6 -2 267 516 -317 893 -394

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 53 59 78 80 53 36 27 31
Inventory Days 20 24 26 40 34 24 30 26
Days Payable 184 227 292 273 274 174 215 221
Cash Conversion Cycle -111 -144 -188 -153 -187 -114 -158 -164
Working Capital Days 7 -2 -136 -91 -32 -13 -39 -36
ROCE % 4% 6% 11% 7% 12% 15% 16%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75% 23.74% 23.74% 23.74% 23.74%
23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33% 56.99% 57.29% 56.93% 54.74%
19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96% 15.36% 15.14% 15.55% 17.59%
6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97% 3.91% 3.84% 3.77% 3.94%
No. of Shareholders 1,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,0091,36,2541,37,8561,40,0281,51,633

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls